Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 21, 2022PLoS ONEOpen Access

Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials

View Full Paper
Ask AI
Bookmark
Share

Authors

SKSteven Kwasi KorangERElena von RohdenAVAreti Angeliki Veroniki

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Korang et al. (2022) studied this question.

synapsesocial.com/papers/6a6f711afebe604dd7085bechttps://doi.org/10.1371/journal.pone.0260733
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial2020 · 1,415 citations
  2. 2Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant2021 · 1,321 citations
  3. 3Vaccines to prevent COVID-19: a protocol for a living systematic review with network meta-analysis including individual patient data (The LIVING VACCINE Project)2020 · 44 citations
  4. 4Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.1.7 Variant2021 · 21 citations
  5. 5Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling2015 · 119 citations